CORC

在结果中检索

CORC

浏览/检索结果: 共44条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Second-generation EGFR and ErbB tyrosine kinase inhibitors as first-line treatments for non-small cell lung cancer 期刊论文
2019, 卷号: 12, 页码: 6535-6548
作者:  Wang, Shouzheng;  Li, Junling
收藏  |  浏览/下载：46/0  |  提交时间：2020/01/03
Accurate Classification of Non-small Cell Lung Cancer (NSCLC) Pathology and Mapping of EGFR Mutation Spatial Distribution by Ambient Mass Spectrometry Imaging 期刊论文
2019, 卷号: 9, 页码: 804
作者:  Zhang, Min;  He, Jiuming;  Li, Tiegang;  Hu, Haixu
收藏  |  浏览/下载：62/0  |  提交时间：2020/01/03
Circular RNA profiling identified as a biomarker for predicting the efficacy of Gefitinib therapy or non-small cell lung cancer 期刊论文
2019, 卷号: 11, 期号: 5, 页码: 1779-+
作者:  Liu, Yu-Tao;  Han, Xiao-Hong;  Xing, Pu-Yuan;  Hu, King-Sheng;  Hao, Xue-Zhi
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03
HIF-1α and NF-κB play important roles in regulating PD-L1 expression by EGFR mutants in non-small cell lung cancer cells 期刊论文
2019
作者:  Guo Rong;  Li Yong;  Wang Zhijie;  Bai Hua;  Duan Jianchun
收藏  |  浏览/下载：2/0  |  提交时间：2020/01/03
The peripheral blood neutrophil-to-lymphocyte ratio is a prognostic predictor for survival of EGFR-mutant nonsmall cell lung cancer patients treated with EGFR-TKIs 期刊论文
2018, 卷号: 97, 期号: 30, 页码: e11648
作者:  Zhang, Yuan;  Feng, Yang-Chun;  Zhu, Hong-Ge;  Xiong, Ting-Chuan;  Hou, Yan-Shen
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
Real-world EGFR testing in patients with stage IIIB/IV non-small-cell lung cancer in North China: A multicenter, non-interventional study 期刊论文
2018, 卷号: 9, 期号: 11, 页码: 1461-1469
作者:  Cheng, Ying;  Wang, Yan;  Zhao, Jun;  Liu, Yunpeng;  Gao, Hongjun
收藏  |  浏览/下载：9/0  |  提交时间：2020/01/03
Serum EGFR gene mutation status via second-generation sequencing and clinical features of patients with advanced lung cancer 期刊论文
2018, 卷号: 11, 期号: 7, 页码: 3551-3558
作者:  Zhang, Zhen;  Zhou, Shengyu
收藏  |  浏览/下载：1/0  |  提交时间：2020/01/03
Structural optimization of diphenylpyrimidine scaffold as potent and selective epidermal growth factor receptor inhibitors against L858R/T790M resistance mutation in nonsmall cell lung cancer 期刊论文
2018, 卷号: 92, 期号: 6, 页码: 1988-1997
作者:  Yi, Yuanyuan;  Wang, Luhong;  Zhao, Dan;  Huang, Shanshan;  Wang, Changyuan
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03
High-dose Icotinib in Advanced NSCLC with EGFR 21 L858R Mutation: A Randomized, Open-Label Phase II Study 期刊论文
2018, 卷号: 13, 期号: 12, 页码: S1049-S1049
作者:  Li, X.;  Zhang, L.;  Jiang, D.;  Wang, Y.;  Zang, A.
收藏  |  浏览/下载：9/0  |  提交时间：2020/01/03
Potential Resistance Mechanisms Revealed by Targeted Sequencing from Lung Adenocarcinoma Patients with Primary Resistance to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs) 期刊论文
2017, 卷号: 12, 期号: 12, 页码: 1766-1778
作者:  Zhong, Jia;  Li, Lei;  Wang, Zhijie;  Bai, Hua;  Gai, Fei
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03

©版权所有 ©2017 CSpace - Powered by CSpace